Skip to content

Pseudoarylsulfatase A Deficiency C1855255

Published: July 22, 2026Updated: August 20, 2026

A benign metabolic condition where an enzyme deficiency does not cause severe symptoms, unlike true arylsulfatase A deficiency. Most people have no health problems. No specific treatment is usually needed.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
E88.9
ICD-11
5A00.0
Body system
metabolic
Severity
mild
Chronic
false

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Fatigue or weight changes

(metabolic)

Mild symptoms that may not significantly impact daily life.

Frequency: Varies

Peripheral neuropathy

(metabolic)

Mild gait disturbance (ataxia)

(metabolic)

Decreased deep tendon reflexes

(metabolic)

Urinary incontinence

(metabolic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Behavioral and nutritional therapy

Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.

lifestyle
2

Regular disease monitoring

Periodic neurological assessments, imaging studies, and laboratory tests to track disease progression and organ involvement. Early detection of complications allows for timely intervention.

monitoring
3

Enzyme replacement therapy

Intravenous administration of recombinant arylsulfatase A to supplement deficient enzyme activity. Treatment aims to reduce sulfatide accumulation in tissues and slow disease progression.

medication

Additional treatment options

Hematopoietic stem cell transplantation

Bone marrow or cord blood transplant to provide functional enzyme-producing cells. Reserved for severe cases or when other therapies are insufficient.

procedure

Substrate reduction therapy

Pharmacological approach to reduce the production of sulfatide substrates, complementing enzyme replacement by decreasing the metabolic burden on remaining enzyme activity.

medication

Supportive care and rehabilitation

Multidisciplinary supportive approach including physical therapy, occupational therapy, and symptomatic treatment of specific manifestations such as seizures or movement disorders.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Pseudoarylsulfatase A Deficiency C1855255?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Medication Comparisons

Compare medications used to treat Pseudoarylsulfatase A Deficiency C1855255. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy